Industry News Roundup
This article was originally published in The Tan Sheet
MediNatura buys Heel Group USA; FDA refuses to file Rock Creek Pharmaceuticals NDI notification; FTC bans businessman from weight-loss industry; AHPA recommends cannabis quality-control regulations; new leadership team at NBTY; FDA cites supplement inflammation claims; and Green Cures signs marketing partners.
You may also be interested in...
Settlements Without Penalties Spur Compliance More Than Litigation – FTC Commissioner
Non-monetary settlements are more effective than litigation at changing consumer product companies’ advertising practices, says FTC Commissioner Christine Wilson. “We see non-monetary settlements curtail behavior and require sometimes fundamental changes in the way companies do business.”
Carlyle Group Gives NBTY Helm To Former Coca-Cola Executive Cahillane
Steven Cahillane, who left his post as president of Coca-Cola Co.’s Americas division in 2013, is moving to NBTY to replace Jeffrey Nagel after the supplement manufacturer and retailer reported flat sales for its most recent earnings period and after net income dropped nearly 12% during the firm’s previous fiscal year.
Between A Rock Creek And A Hard Place: Firm Stops Supplement Sales, Weathers Litigation
Rock Creek Pharmaceuticals faces investor and consumer class-action complaints on top of ending sales of its nutritionals following an FDA warning. Moreover, the company name is known more in connection with federal officials’ investigation of the former governor of Virginia than for its products.